Identification and Management of the High-Risk Patient
8:00 AM–4:00 PM
Course Description:
Given the prevalence of breast cancer and the shortage of certified cancer genetic counselors, breast surgeons may find themselves leading cancer genetic testing. This course is designed to provide you with all the resources and knowledge necessary to perform appropriate pre and posttest counseling and select and order and interpret cancer genetic testing. Furthermore, we aim to better aid you in post-test discussions and residual familial cancer risk for those not harboring a pathogenic mutation. Finally, we will guide you on counseling patients regarding cancer risk factors beyond genetics, and risk mitigation.
Course Objectives:
At the conclusion of this course, participants should be able to:
- Better understand the array of germline cancer genetic panels and their differences
- Better understand pre and posttest counseling
- Better understand assessment of residual cancer risk, including RNA snips, after a non-informative cancer genetic test result
- Better optimize high risk breast cancer screening strategies
- Better understand risk reduction strategies
CME Credit Information:
The American Society of Breast Surgeons designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Agenda:
| 7:30 AM | Check-in and Breakfast (Magnolia Lawn)
|
| 8:00 AM | Welcome and Introduction
Jennifer K. Plichta, MD, MS, FACS; Ashley R. Stuckey, MD, FACOG, FACS |
| 8:10 AM | Who, What, When, Where: Risk Assessment and Who Needs Germline Genetic Testing
Jennifer K. Plichta, MD, MS, FACS |
| 8:55 AM | How to Choose a Test
Barry Rosen, MD, FACS |
| 9:25 AM | Pre and Post-test Counseling: Interpreting Results and Understanding Risk Profiles of Different Genes
Cory A. Donovan, MD |
| 9:55 AM | Q&A
|
| 10:15 AM | Break
|
| 10:30 AM | High-Risk Breast Cancer Screening Strategies in Mutation Carriers
Cory A. Donovan, MD |
| 11:00 AM | Prophylaxis and Prevention in Mutation Carriers
Ashley R. Stuckey, MD, FACOG, FACS |
| 11:30 AM | Q&A
|
| 11:45 AM | Lunch (Magnolia Lawn)
|
| 12:30 PM | Residual Risk Assessment and Risk Reduction Management in Patients without Mutations
Anita Johnson, MD, FACS |
| 1:15 PM | AI in Genetics: The Next Frontier
Jennifer Scalia, MS |
| 2:00 PM | Q&A
|
| 2:15 PM | Break
|
| 2:30 PM | How to Implement Comprehensive Germline Genetic Testing in Clinic on Monday
Barry Rosen, MD, FACS |
| 3:00 PM | Panel Discussion
Cory A. Donovan, MD; Anita Johnson, MD, FACS; Jennifer K. Plichta, MD, MS, FACS; Jennifer Scalia, MS; Ashley R. Stuckey, MD, FACOG, FACS |
| 3:30 PM | Wrap-up
|
| 4:00 PM | Adjourn
|
